Literature DB >> 16455964

CD11b+/Gr-1+ myeloid suppressor cells cause T cell dysfunction after traumatic stress.

Valeriya P Makarenkova1, Vishal Bansal, Benjamin M Matta, Lori Ann Perez, Juan B Ochoa.   

Abstract

T cell dysfunction that occurs after surgery or trauma is associated with a poor clinical outcome. We describe that myeloid suppressor cells expressing CD11b(+)/Gr-1(+) markers invade the spleen after traumatic stress and suppress T cell function through the production of arginase 1. We created a consistent model of traumatic stress in C57BL/6 mice to perform this work. A significant number of CD11b(+)/Gr-1(+) cells expressing arginase 1 accumulated in T cell zones around the germinal centers of the white pulp of the spleen within 6 h of trauma and lasted for at least 72 h. Increased arginase activity and arginase 1 expression, along with increased [(3)H]arginine uptake, l-arginine depletion, and l-ornithine accumulation in the culture medium, were observed exclusively in CD11b(+)/Gr-1(+) cells after traumatic stress. Flow cytometry revealed CD11b(+)/Gr-1(+) as a heterogeneous myeloid suppressor cell also expressing low levels of MHC class I and II, CD80, CD86, CD31, and others. When compared with controls, trauma-induced CD11b(+)/Gr-1(+) cells significantly inhibited CD3/CD28-mediated T cell proliferation, TCR zeta-chain expression, and IL-2 production. The suppressive effects by trauma CD11b(+)/Gr-1(+) cells were overcome with the arginase antagonist N-hydroxy-nor-l-arginine or extrasupplementation of medium with l-arginine. Poor Ag-presenting capacity of control and trauma-induced CD11b(+)/Gr-1(+) cells was detected in allogeneic murine leukocyte reaction. This study demonstrates that CD11b(+)/Gr-1(+) cells invade the spleen following traumatic stress and cause T cell dysfunction by an arginase-mediated mechanism, probably that of arginine depletion. Understanding the mechanism of immune suppression by these cells has important clinical implications in the treatment of immune dysfunction after trauma or surgery.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16455964     DOI: 10.4049/jimmunol.176.4.2085

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  145 in total

1.  Tumor-infiltrating, myeloid-derived suppressor cells inhibit T cell activity by nitric oxide production in an intracranial rat glioma + vaccination model.

Authors:  Wentao Jia; Colleen Jackson-Cook; Martin R Graf
Journal:  J Neuroimmunol       Date:  2010-05-08       Impact factor: 3.478

2.  Genetic inversion in mast cell-deficient (Wsh) mice interrupts corin and manifests as hematopoietic and cardiac aberrancy.

Authors:  Peter A Nigrovic; Daniel H D Gray; Tatiana Jones; Jenny Hallgren; Frank C Kuo; Blair Chaletzky; Michael Gurish; Diane Mathis; Christophe Benoist; David M Lee
Journal:  Am J Pathol       Date:  2008-11-06       Impact factor: 4.307

3.  Myeloid-derived suppressor cells control microbial sepsis.

Authors:  Marc Derive; Youcef Bouazza; Corentine Alauzet; Sébastien Gibot
Journal:  Intensive Care Med       Date:  2012-05-03       Impact factor: 17.440

4.  Sepsis Pathophysiology, Chronic Critical Illness, and Persistent Inflammation-Immunosuppression and Catabolism Syndrome.

Authors:  Juan C Mira; Lori F Gentile; Brittany J Mathias; Philip A Efron; Scott C Brakenridge; Alicia M Mohr; Frederick A Moore; Lyle L Moldawer
Journal:  Crit Care Med       Date:  2017-02       Impact factor: 7.598

5.  Conditions that diminish myeloid-derived suppressor cell activities stimulate cross-protective immunity.

Authors:  Douglas M Heithoff; Elena Y Enioutina; Diana Bareyan; Raymond A Daynes; Michael J Mahan
Journal:  Infect Immun       Date:  2008-09-02       Impact factor: 3.441

6.  Bacterial signalling overrides cytokine signalling and modifies dendritic cell differentiation.

Authors:  Julie M Davies; Barbara Sheil; Fergus Shanahan
Journal:  Immunology       Date:  2009-03-23       Impact factor: 7.397

7.  The effects of red cell transfusion donor age on nosocomial infection among trauma patients.

Authors:  Tyler J Loftus; Ryan M Thomas; Travis W Murphy; Linda L Nguyen; Frederick A Moore; Scott C Brakenridge; Philip A Efron; Alicia M Mohr
Journal:  Am J Surg       Date:  2017-07-12       Impact factor: 2.565

Review 8.  Adjuvants and myeloid-derived suppressor cells: enemies or allies in therapeutic cancer vaccination.

Authors:  Audry Fernández; Liliana Oliver; Rydell Alvarez; Luis E Fernández; Kelvin P Lee; Circe Mesa
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 9.  Gammadelta T-cells: potential regulators of the post-burn inflammatory response.

Authors:  Martin G Schwacha
Journal:  Burns       Date:  2008-10-31       Impact factor: 2.744

10.  Inducible Nitric Oxide Synthase and CD11b+Gr1+ Cells Impair Lymphatic Contraction of Tumor-Draining Lymphatic Vessels.

Authors:  Shan Liao; Echoe M Bouta; Linda M Morris; Dennis Jones; Rakesh K Jain; Timothy P Padera
Journal:  Lymphat Res Biol       Date:  2018-10-24       Impact factor: 2.589

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.